Zobrazeno 1 - 10
of 158
pro vyhledávání: '"V C, Jordan"'
Publikováno v:
Progress in the Management of the Menopause ISBN: 9781003076575
Progress in the Management of the Menopause
Progress in the Management of the Menopause
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4d62cda89e9426ad0e17981dd6a166a
https://doi.org/10.1201/9781003076575-4
https://doi.org/10.1201/9781003076575-4
Publikováno v:
British Journal of Cancer
Background: Oestrogen (E2) induces apoptosis in long-term E2-deprived MCF7 cells (MCF7:5C). Taxanes have been used extensively in the treatment of early and advanced breast cancer. We have interrogated the sequence of events that involve the apoptoti
Publikováno v:
European Journal of Endocrinology. 143:427-430
OBJECTIVE: Tamoxifen and raloxifene, selective estrogen receptor modulators, decrease serum concentrations of total cholesterol; however, the effect of these drugs on triglyceride metabolism is unclear. In the present study, we investigated the in vi
Autor:
V. C. Jordan
Publikováno v:
Endocrine Reviews. 20:253-278
Autor:
R M, O'Regan, A, Cisneros, G M, England, J I, MacGregor, H D, Muenzner, V J, Assikis, M M, Bilimoria, M, Piette, Y P, Dragan, H C, Pitot, R, Chatterton, V C, Jordan
Publikováno v:
JNCI Journal of the National Cancer Institute. 90:1552-1558
Background Tamoxifen has been shown to promote the growth of human endometrial tumors implanted in athymic mice, and it has been associated with a twofold to threefold increase in endometrial cancer. Toremifene, a chlorinated derivative of tamoxifen,
Autor:
V C, Jordan
Publikováno v:
Scientific American. 279:60-67
Publikováno v:
Toxicological Sciences. 43:129-138
Autor:
V. C. Jordan, C. Tellez
Publikováno v:
Surgical Oncology Clinics of North America. 4:751-777
Endocrine therapy for breast cancer has been used for almost a century, but because of the enormous success of tamoxifen there has been a resurgence of interest by the pharmaceutical industry to develop new and innovative endocrine therapies. Overall
Autor:
V C Jordan
Publikováno v:
Annual Review of Pharmacology and Toxicology. 35:195-211
Tamoxifen, a nonsteroidal antiestrogen, is the endocrine therapy of choice for all stages of breast cancer. There are six million women-years of experience with tamoxifen, and the drug has produced survival advantages in node-positive and node-negati
Publikováno v:
Endocrine Related Cancer. 2:45-51